Tupper Colleen - Net Worth and Insider Trading
Tupper Colleen Net Worth
The estimated net worth of Tupper Colleen is at least $4 Million dollars as of 2024-11-05. Tupper Colleen is the EVP & CFO of Collegium Pharmaceutical Inc and owns about 130,845 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $4 Million. Details can be seen in Tupper Colleen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tupper Colleen has not made any transactions after 2024-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tupper Colleen
Tupper Colleen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tupper Colleen owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .
Click here to see the complete history of Tupper Colleen’s form 4 insider trades.
Insider Ownership Summary of Tupper Colleen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2024-05-28 | EVP & Chief Financial Officer |
Tupper Colleen Latest Holdings Summary
Tupper Colleen currently owns a total of 1 stock. Tupper Colleen owns 130,845 shares of Collegium Pharmaceutical Inc (COLL) as of May 28, 2024, with a value of $4 Million.
Latest Holdings of Tupper Colleen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2024-05-28 | 130,845 | 32.71 | 4,279,940 |
Holding Weightings of Tupper Colleen
Tupper Colleen Form 4 Trading Tracker
According to the SEC Form 4 filings, Tupper Colleen has made a total of 2 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 19,710 shares on May 28, 2024, which brought Tupper Colleen around $674,279.
Insider Trading History of Tupper Colleen
- 1
Tupper Colleen Trading Performance
Tupper Colleen Ownership Network
Ownership Network List of Tupper Colleen
Ownership Network Relation of Tupper Colleen
Tupper Colleen Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Tupper Colleen is the EVP & Chief Financial Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Commercial Officer Scott Dreyer .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Tupper Colleen made 1 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 19,710. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .
In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Tupper Colleen Mailing Address
Above is the net worth, insider trading, and ownership report for Tupper Colleen. You might contact Tupper Colleen via mailing address: C/o Collegium Pharmaceutical, Inc., 100 Technology Center Drive, Stoughton Ma 02072.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
